Literature DB >> 26713366

Suppression of Slit2/Robo1 mediated HUVEC migration by Robo4.

Satoshi Enomoto1, Kenichi Mitsui1, Takeshi Kawamura2, Hiroko Iwanari1, Kenji Daigo1, Keiko Horiuchi1, Takashi Minami3, Tatsuhiko Kodama3, Takao Hamakubo4.   

Abstract

Slit proteins and their receptors, the Roundabout (Robo) family, are known to have a pivotal role in the vascular system. Slit2/Robo1 regulates the migration of human umbilical vein endothelial cells (HUVECs) and tumor-associated endothelial cells. Robo4, the endothelial-specific Robo, is also considered to be involved in vascular cell migration. However, the Slit/Robo signaling pathway is still unclear. Using a Boyden chamber assay, we found that Slit2 induces the migration of HUVECs under a Robo4 knockdown condition. This effect disappeared in Robo1 knockdown cells. The co-existence of the N-terminal extracellular portion of Robo1 blocked the Slit2-evoked migration of HUVECs, while that of Robo4 caused no effect. These results show that the Slit2 signal is transduced through Robo1, while the negative regulation of Robo4 is an intracellular event. Targeted proteomics using an anti-Robo1 monoclonal antibody identified CdGAP, an adhesion-localized Rac1-and Cdc42-specific GTPase activating protein, as a candidate for Slit2/Robo1 signaling. Robo1 and CdGAP were co-immunoprecipitated from CHO cells co-transfected with Robo1 and CdGAP genes. These results suggest that Slit2/Robo1 binding exerts an effect on cell migration, which is negatively regulated by Robo4, and Robo1 may function by interacting with CdGAP in HUVECs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CdGAP; HUVEC; Migration; Robo1; Robo4; Slit2

Mesh:

Substances:

Year:  2015        PMID: 26713366     DOI: 10.1016/j.bbrc.2015.12.075

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

Review 1.  The role of Slit-Robo signaling in the regulation of tissue barriers.

Authors:  Ming-Fang Wu; Chen-Yi Liao; Ling-Yi Wang; Jinghua Tsai Chang
Journal:  Tissue Barriers       Date:  2017-06-08

2.  Inhibitory Effect of Slit2-N on VEGF165-induced proliferation of vascular endothelia via Slit2-N-Robo4-Akt pathway in choroidal neovascularization.

Authors:  Shaoqiu Jiang; Yong Du; Danning Liu; Junchi He; Yike Huang; Ke Qin; Xiyuan Zhou
Journal:  Cell Cycle       Date:  2019-05-22       Impact factor: 4.534

3.  Roundabout1 distribution in neoplastic and non-neoplastic diseases with a focus on neoangiogenesis.

Authors:  Shuying Jiang; Takao Hamakubo; Kenichi Mitsui; Ren Yagami; Yukio Fujiyoshi; Yoichi Ajioka; Makoto Naito
Journal:  Int J Clin Exp Pathol       Date:  2018-12-01

Review 4.  Regulatory mechanisms of Robo4 and their effects on angiogenesis.

Authors:  Chang Dai; Qiaoyun Gong; Yan Cheng; Guanfang Su
Journal:  Biosci Rep       Date:  2019-07-10       Impact factor: 3.840

5.  jouvence, a new human snoRNA involved in the control of cell proliferation.

Authors:  Flaria El-Khoury; Jérôme Bignon; Jean-René Martin
Journal:  BMC Genomics       Date:  2020-11-23       Impact factor: 3.969

6.  Silicone elastomer gel impregnated with 20(S)-protopanaxadiol-loaded nanostructured lipid carriers for ordered diabetic ulcer recovery.

Authors:  Di Sun; Shi-Yan Guo; Li Yang; Ya-Ru Wang; Xiao-Hui Wei; Sha Song; Yi-Wei Yang; Yong Gan; Zheng-Tao Wang
Journal:  Acta Pharmacol Sin       Date:  2019-09-18       Impact factor: 6.150

Review 7.  Neurovascular patterning cues and implications for central and peripheral neurological disease.

Authors:  Nicholas T Gamboa; Philipp Taussky; Min S Park; William T Couldwell; Mark A Mahan; M Yashar S Kalani
Journal:  Surg Neurol Int       Date:  2017-09-06

8.  Survival-based bioinformatics analysis to identify hub genes and key pathways in non-small cell lung cancer.

Authors:  Chunliang Liu; Yu Chen; Yuqi Deng; Yu Dong; Jixuan Jiang; Si Chen; Wenfeng Kang; Jiong Deng; Haipeng Sun
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.